Search Results

Elvitegravir 25 mg  | ≥98%

LKT Laboratories, Inc.

Integrase inhibitor.

More Information Supplier Page

×

Elvitegravir

Elvitegravir 50 mg  | ≥98%

LKT Laboratories, Inc.

Integrase inhibitor.

More Information Supplier Page

×

Elvitegravir

Abacavir Sulfate 50 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (guanosine) analog; RT, guanylyl cyclase, telomerase inhibitor.

More Information Supplier Page

×

Abacavir Sulfate

Abacavir Sulfate 25 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (guanosine) analog; RT, guanylyl cyclase, telomerase inhibitor.

More Information Supplier Page

×

Abacavir Sulfate

Abacavir Sulfate 10 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (guanosine) analog; RT, guanylyl cyclase, telomerase inhibitor.

More Information Supplier Page

×

Abacavir Sulfate

Emtricitabine 10 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (cytidine) analog; RT and telomerase inhibitor.

More Information Supplier Page

×

Emtricitabine

Emtricitabine 25 mg  | ≥98%

LKT Laboratories, Inc.

Nucleoside (cytidine) analog; RT and telomerase inhibitor.

More Information Supplier Page

×

Emtricitabine

Efavirenz 50 mg  | ≥98%

LKT Laboratories, Inc.

Non-nucleoside RT inhibitor.

More Information Supplier Page

×

Efavirenz

Dimethyl Fumarate 100 g  | ≥98%

LKT Laboratories, Inc.

Fumaric acid methyl ester; nAChR agonist, indirect Nrf2 activator.

More Information Supplier Page

×

Dimethyl Fumarate

Dimethyl Fumarate 25 g  | ≥98%

LKT Laboratories, Inc.

Fumaric acid methyl ester; nAChR agonist, indirect Nrf2 activator.

More Information Supplier Page

×

Dimethyl Fumarate